Hollowood, Christopher John, Dr
At least 4 active companies
These details are public data from the Companies House register.
- Nationality
- British
- Country of residence
- England
Appointments 4 current
Not a complete list. See all appointments on Companies House
Director · Appointed 28 March 2024
Active
Net assets £53, 2024 accounts (newer filed) · Incorporated 2023
Director · Appointed 29 February 2024
Active
Group accounts · Incorporated 2023
Director · Appointed 18 August 2022
Active
Group accounts · Incorporated 2022
Director · Appointed 19 December 2016
Active
Group accounts · Incorporated 2016
Former appointments (10)
Director · Appointed 11 September 2024 · Resigned 16 December 2024
Company active
Director · Appointed 20 July 2023 · Resigned 16 December 2024
Company active
Director · Appointed 1 January 2023 · Resigned 16 December 2024
Company active
Director · Appointed 18 October 2022 · Resigned 18 January 2024
Company active
Director · Appointed 15 October 2022 · Resigned 31 October 2023
Company active
Director · Appointed 23 August 2022 · Resigned 16 December 2024
Company active
Director · Appointed 29 October 2020 · Resigned 27 June 2023
Company active
Director · Appointed 1 April 2020 · Resigned 8 October 2024
Company active
Director · Appointed 2 February 2018 · Resigned 10 October 2023
Company active
Director · Appointed 19 December 2016 · Resigned 16 December 2024
Company active
Works with
Officers serving alongside Hollowood, Christopher John, Dr
Director at Beacon Therapeutics Holdings Limited
Chester, Cariad Dixon
Director at Beacon Therapeutics Holdings Limited
Fellows, David Andrew
Director at Beacon Therapeutics Holdings Limited
Hirst, Julian Clement
Secretary at Yellowstone Biosciences Limited